Indian entrepreneur Deepinder Goyal launches US$25 million longevity-research fund

Indian-origin entrepreneur Deepinder Goyal has announced the launch of ‘Continue Research’, a US$25 million personal fund aimed at accelerating human-longevity research. The fund will back early-stage companies working in age-related diseases, cognition, and regulatory-AI in healthtech. The move reflects a broader trend of tech founders channeling capital into biotech and high-science ventures, even as India’s start-up funding in deep-tech remains weak. Analysts believe founder-led funds like this could help bridge the gap in early-stage capital for frontier science.